Loading...

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Alzheimer's Association International Conference 2026 banner

Showing 6 results for author "Nalin Payakachat".

Thumbnail for Quantification Of Benefit-risk In Amyloid-targeting Therapies For Cognitively Unimpaired Alzheimer's Disease

11960

Quantification Of Benefit-risk In Amyloid-targeting Therapies For Cognitively Unimpaired Alzheimer's Disease

Oralee J Varnado, Matthew Quaife, Jaein Seo, Antje Tockhorn-Heidenreich, Nalin Payakachat, Yasmijn Slaghekke, Álvaro Alberto Gutiérrez-Vargas, J. Scott Andrews, Niklas Mattsson-Carlgren

Eli Lilly and Company, Indianapolis, IN, USA, PPD Evidera Patient-Centered Research, Thermo Fisher Scientific, London, UK, PPD Evidera Patient-Centered Research, Thermo Fisher Scientific, Waltham, MA, USA, Clin...

Poster Presenter: Oralee Varnado

Thumbnail for Defining Meaningful Change In Alzheimer’S Disease Through Lived Experience: Implications For The Clinical Dementia Rating Scale

13336

Defining Meaningful Change In Alzheimer’S Disease Through Lived Experience: Implications For The Clinical Dementia Rating Scale

J. Scott Andrews, Carla DeMuro, Alette Wessels, Jacquie Mogle, Nalin Payakachat, Audra Gold, Sean Halpin, Antje Tockhorn-Heidenreich, Emily Bratlee-Whitaker, Alice Farquharson, Niklas Mattso...

Eli Lilly and Company, RTI Health Solutions, Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Medical Faculty, Lund University, Lund, Sweden

Poster Presenter: Jeffrey Andrews

Thumbnail for Risk Algorithms To Predict Elevated Plasma P-tau217 Status: A Cross-sectional Analysis

2141

Risk Algorithms To Predict Elevated Plasma P-tau217 Status: A Cross-sectional Analysis

Nalin Payakachat, E. Jolanda Muenzel, Dulanji Kuruppu, Katie A. Vandergriff, Yun-Fei Chen, Karen Holdridge, Nicolae Done, Urvi Desai, Pete Zuckerman, Michael S. Rafii, Roy Yaari, Reisa A. Sp...

Eli Lilly and Company, Indianapolis, USA, Analysis Group, Boston, USA, University of Southern California, Los Angeles, USA, Harvard Medical School, Boston, USA

Poster Presenter: Nalin Payakachat

Thumbnail for Drivers Of Increased Healthcare Utilization And Medicare Payments During Preclinical Alzheimer's Disease Progression

441

Drivers Of Increased Healthcare Utilization And Medicare Payments During Preclinical Alzheimer's Disease Progression

Julie Beyrer, Zachary Sheff, Nalin Payakachat, Yun-Fei Chen, Joanna Kubisiak, Angelina Lee, Karen C. Holdridge, Roy Yaari, Paul Aisen, Michael S. Rafii, Reisa A. Sperling

Eli Lilly and Company, Indianapolis, Indiana, USA, Westat, Bethesda, MD, USA, University of Southern California, San Diego, CA, USA, Brigham and Women’s Hospital, Massachusetts General Hospital, Harvard Medical...

Poster Presenter: Julie Beyrer

Thumbnail for Neurocognitive, Biomarker, And Health Outcomes In Those At Risk For Alzheimer’s Disease Symptoms: ANCHOR-AD Study Design

9036

Neurocognitive, Biomarker, And Health Outcomes In Those At Risk For Alzheimer’s Disease Symptoms: ANCHOR-AD Study Design

Sterling Johnson, Nalin Payakachat, Michelle Mielke, Kellen Petersen, Alette Wessels, Jolanda Muenzel, Dulanji Kuruppu, Rose Beck, Scott Andrews, Yoshiki Niimi, Roy Yaari, Takeshi Iwatsubo,...

Wake Forest University School of Medicine, Eli Lilly and Company, Washington University School of Medicine, University of Wisconsin, University of Tokyo Hospital, University of Tokyo National Center of Neurolog...

Poster Presenter: Nalin Payakachat

aaic2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.